Publications

In this section we list some publications by our members:

2015

​Milne RJ, Beasley R. Hospital admissions for chronic obstructive pulmonary disease in New Zealand. NZ Med J. 2015 Jan;128(1408):23-35. Available at www.nzma.org.nz/

2014

Selak V, Elley R, ..., Milne RJ, ..., Rodgers A. Effect of fixed dose combination therapy on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. BMJ. 2014;348:g3318. doi: 10.1136/bmj.g3318

Milne RJ, Hockey H, Rea H. Long-term air humidification therapy is cost effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis. Value Health. 2014;17:320-327. doi: 10.1016/j.jval.2014.01.007

2013

Husereau D, Drummond M, Petrou S, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Pharmacoeconomics. 2013 May;31(5):361-7. doi: 10.1007/s40273-013-0032-y

2012

Milne RJ, Lennon D, Stewart J, et al. Incidence of acute rheumatic fever in New Zealand children and youth. J Ped Child Health. 2012;48(8):685-691. doi: 10.1111/j.1440-1754.2012.02447.x

Milne RJ, Lennon D, Stewart J, et al. Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand. J Ped Child Health. 2012;48(8):692-697. doi: 10.1111/j.1440-1754.2012.02446.x

Have your publication featured here (members only)

© 2019 by International Society for Pharmacoeconomics and Outcomes Research (ISPOR) NZ Chapter